President Trump has issued an executive order intending to lower U.S. drug prices by mandating that drug companies match the prices paid in other developed countries. This initiative, described as "most favored nation" pricing, could lead to investigations and consequences for companies that do not comply. The order also allows for the importation of drugs from other countries and seeks to enhance direct-to-consumer sales. The goal is to address the disparity in drug costs, where Americans pay significantly more than their international counterparts due to differing pricing regulations.
President Trump announced an executive order aimed at reducing U.S. drug prices, tying them to lower prices paid in other developed countries, emphasizing a "most favored nation" stance.
He indicated that drug companies must lower their prices or face investigations and potential consequences, stating the U.S. will no longer subsidize global health spending through high medication costs.
Collection
[
|
...
]